ABP
ABP
NASDAQ · Biotechnology

Abpro Holdings Inc

$0.12
-0.02 (-15.69%)
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +29,350.8% upside
Low Target $28.98
Average Target $35.93
High Target $50.96
Current Price $0.12
Current
$0.12
Target
$35.93
$28.98 $35.93 avg $50.96
Scenario Analysis
Bear Case
$28.98
23,654.1%
Low target
Base Case
$35.93
+29,350.8%
Avg target
Bull Case
$50.96
+41,670.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$35.93
+163.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.5%